Results 111 to 120 of about 477,265 (189)
Chaperone-Assisted Host–Guest Interactions Revealed by Single-Molecule Force Spectroscopy
The recent discovery of ultra-high binding affinities in cucurbit[7]uril (CB7)-based host–guest pairs in an aqueous environment has rendered CB7 a rather attractive material in analytical and biomedical applications.
Lyle Isaacs (365049) +6 more
core +1 more source
Correction to: A pharmacological chaperone improves memory by reducing Aβ and tau neuropathology in a mouse model with plaques and tangles. [PDF]
Li JG +4 more
europepmc +1 more source
Pharmacological chaperone for the structured domain of human prion protein.
In prion diseases, the misfolded protein aggregates are derived from cellular prion protein (PrP(C)). Numerous ligands have been reported to bind to human PrP(C) (huPrP), but none to the structured region with the affinity required for a pharmacological ...
Emmanuel Risse +38 more
core +1 more source
Heat shock proteins belong to a highly conserved family of chaperone proteins, and in addition to their participation in the regulation of cellular proteostasis (folding of polypeptides and proteins, disaggregation of incorrectly folded peptides, and ...
Elena Mikhailova +3 more
doaj +1 more source
Functional rescue and AI analysis of a human inactivating GPCR mutation using a small molecule
G protein-coupled receptors (GPCRs) carry out the majority of cellular transmembrane signaling. Many pathologies have underlying GPCR mutations, most of which cause misfolding and GPCR cell surface trafficking failure.
Debajyoti Das +10 more
doaj +1 more source
Intoxication of mammalian cells with binary clostridial enterotoxins is inhibited by the combination of pharmacological chaperone inhibitors. [PDF]
Ernst K, Sailer J, Braune M, Barth H.
europepmc +1 more source
Chaperone-mediated autophagy degrades mutant p53
Accumulation of mutant p53 proteins contributes to tumor development and metastasis, yet little is known abut how to selectively reduce the cellular load of mutant p53.
Yuan, Junying +10 more
core +1 more source
IntroductionThe TP53 mutations in Non-Small Cell Lung Cancer (NSCLC) remain a formidable clinical challenge. Current strategies, using the covalent binder APR-246, are limited by off-target toxicity and resistance.MethodsThis study screens 1,580 Bacillus-
Adeline Celina Rufus +3 more
doaj +1 more source
Misfolding of Lysosomal α-Galactosidase a in a Fly Model and Its Alleviation by the Pharmacological Chaperone Migalastat. [PDF]
Braunstein H +5 more
europepmc +1 more source

